Liver scanner reliability put to the test
NCT ID NCT06877026
First seen Mar 14, 2026 · Last updated Jun 22, 2026 · Updated 18 times
Summary
This study tested how repeatable and reproducible FibroScan results are when different operators use the device on different days. 108 adults with fatty liver or alcohol-related liver disease had multiple scans and blood tests over two visits. The goal was to see if a guided version of the scan gives more consistent results than the standard version.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King's College Hospital NHS Foundation Trust
London, England, SE5 9RS, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could confirm that FibroScan gives reliable liver stiffness readings, making doctors more confident in using it to monitor liver disease without invasive biopsies.
What could go wrong
This is a small, completed study focused on device reliability, not on treating or curing disease. Results may not apply to all liver conditions or settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.